Revolutionizing in vivo gene delivery to usher in a new era of genetic medicines.
Archives
Mahzi Therapeutics
A biotechnology company.
MBrace Therapeutics
Developing novel antibody drug conjugates (ADCs) against novel targets in multiple solid tumors.
Mythic Therapeutics
Pioneering a powerful new approach to improving the effectiveness of antibody-drug conjugates (ADCs) and other antibody-based therapeutics.
Ocelot Bio
On a mission to revolutionize treatment options for patients with severe liver disease.
Corvidia
Targeting inflammation in cardiovascular and renal disease.
Federation Bio
The future of microbiome therapeutics.
Cyteir Therapeutics
Leader in the discovery and development of novel therapeutics based on the biology of DNA repair and synthetic lethality for the treatment of cancer and autoimmune diseases.
Encoded Therapeutics
Harnessing the regulatory genome to create next-generation molecular therapies.
REGENXBIO
REGENXBIO is the leading next-generation AAV gene therapy company, developing a new class of
personalized therapies based on its proprietary NAV® Technology platform for a range of severe
diseases with serious unmet needs.